Molecular diagnosis of central nervous system opportunistic infections in HIV-infected zambian adults

Clinical Infectious Diseases

Volumn 58, Issue 12, 2014, Pages 1771-1777

  Siddiqi, Omar K ^a,b   Ghebremichael, Musie ^c   Dang, Xin ^a   Atadzhanov, Masharip ^b   Kaonga, Patrick ^b   Khoury, Michael N ^a   Koralnik, Igor J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cerebrospinal fluid; HIV; opportunistic infections; PCR; Zambia

Indexed keywords

PRIMER DNA; BACTERIAL DNA; DNA; FUNGAL DNA; PROTOZOAL DNA; VIRUS DNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CRYPTOCOCCUS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; TERTIARY CARE CENTER; TOXOPLASMA GONDII; VARICELLA ZOSTER VIRUS; ZAMBIA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM INFECTIONS; CROSS-SECTIONAL STUDY; CRYPTOCOCCOSIS; GENETICS; HERPESVIRIDAE; MICROBIOLOGY; MORTALITY; PARASITOLOGY; SEIZURE; TOXOPLASMA; TOXOPLASMOSIS; VIRUS DISEASES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM INFECTIONS; CROSS-SECTIONAL STUDIES; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DNA; DNA, BACTERIAL; DNA, FUNGAL; DNA, PROTOZOAN; DNA, VIRAL; FEMALE; HERPESVIRIDAE; HUMANS; JC VIRUS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; SEIZURES; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA; TOXOPLASMOSIS; VIRUS DISEASES; ZAMBIA;

EID: 84901793941     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu191     Document Type: Article

References (35)

1. Portegies P, Berger JR. HIV/AIDS and the nervous system. In: Aminoff MJ, Boller F, Swaab DF, eds. Handbook of clinical neurology. Vol. 85. Edinburgh: Elsevier, 2007:1-2.
2. United Nations Joint Programme on HIV/AIDS. UNAIDS report on the global AIDS epidemic 2010. Available at: http://www.unaids.org/documents/20101123- globalreport-em.pdf. Accessed 31 January 2014.
3. United Nations Joint Programme on HIV/AIDS. Zambia. Available at: http://www.unaids.org/en/regionscountries/countries/zambia/. Accessed 31 January 2014.
4. Ryschkewitsch C, Jensen P, Hou J, Fahle G, Fischer S, Major EO. Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods 2004; 121:217-21.
5. Broccolo F, Scarpellini P, Locatelli G, et al. Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays. J Clin Microbiol 2003; 41:4565-72.
6. Mesquita RT, Ziegler AP, Hiramoto RM, Vidal JE, Pereira-Chioccola VL. Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients. J Med Microbiol 2010; 59(pt 6):641-7.
7. Weidmann M, Meyer-Konig U, Hufert FT. Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR. J Clin Microbiol 2003; 41:1565-8.
8. Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. QJM 2004; 97:413-21.
9. Martelius T, Lappalainen M, Palomaki M, Anttila VJ. Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid. BMC Infect Dis 2011; 11:281.
10. Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis 2005; 191:234-7.
11. Kelly MJ, Benjamin LA, Cartwright K, et al. Epstein-Barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis 2012; 205: 106-10.
12. Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 2008; 18:305-19.
13. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303-27.
14. Dellemijn PL, Brandenburg A, Niesters HG, van den Bent MJ, Rothbarth PH, Vlasveld LT. Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant. Bone Marrow Transplant 1995; 16:311-2.
15. Mwaba P, Mwansa J, Chintu C, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001; 77:769-73.
16. Shankar SK, Satishchandra P, Mahadevan A, et al. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol 2003; 9(suppl 1): 59-67.
17. Gheuens S, Wuthrich C, Koralnik IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 8:189-215.
18. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 1996; 45: 472-6.
19. Dupon M, Cazenave J, Pellegrin JL, et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 1995; 33:2421-6.
20. Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, Miro JM. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol 2005; 11 (suppl 3):72-82.
21. Zumla A, Savva D, Wheeler RB, et al. Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 1991; 85:227-9.
22. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15(suppl 4):S97-108.
23. Siddiqi O, Birbeck GL. Safe treatment of seizures in the setting of HIV/AIDS. Curr Treat Options Neurol 2013; 15:529-43.
24. Atadzhanov M, Haworth A, Chomba EN, Mbewe EK, Birbeck GL. Epilepsy-associated stigma in Zambia: what factors predict greater felt stigma in a highly stigmatized population? Epilepsy Behav 2010; 19:414-8.
25. Chomba EN, Haworth A, Mbewe E, et al. The current availability of antiepileptic drugs in Zambia: implications for the ILAE/WHO "out of the shadows" campaign. Am J Trop Med Hyg 2010; 83:571-4.
26. Fortgang IS, Moore RD. Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:365-72.
27. Turner BJ, Ball JK. Variations in inpatient mortality for AIDS in a national sample of hospitals. J Acquir Immune Defic Syndr 1992; 5:978-87.
28. Centers for Disease Control and Prevention. Differences between HIVInfected men and women in antiretroviral therapy outcomes-six African countries, 2004-2012. MMWR Morb Mortal Wkly Rep 2013; 62:945-52.
29. Mosha F, Muchunguzi V, Matee M, et al. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. BMC Public Health 2013; 13:38.
30. Cornell M, Schomaker M, Garone DB, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A multicentre cohort study. PLoS Med 2012; 9:e1001304.
31. World Health Organization. WHO monitoring of Xpert MTB/RIF rollout. Available at: http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html. Accessed 28 January 2014.
32. World Health Organization. Public-private partnership announces immediate 40 percent cost reduction for rapid TB test. Available at: http://www.who.int/ tb/features-archive/GeneXpert-press-release-final.pdf. Accessed 3 February 2014.
33. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J 1999; 75:133-40.
34. Bank TW. Zambia. Available at: http://data.worldbank.org/country/zambia. Accessed 17 September 2014.
35. Benjamin LA, Kelly M, Cohen D, et al. Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi. Infection 2013; 41:27-31.